Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Inaba

Showing results (101-110 of 430) with videos related to

Pageof 43
Sort By:
Nephron|February 4, 2019
Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary HyperparathyroidismSenji Okuno, Masaaki Inaba, Eiji Ishimura, et al.
Journal of Cellular Biochemistry|March 5, 2015
Oncostatin M Promotes Osteoblastic Differentiation of Human Vascular Smooth Muscle Cells Through JAK3-STAT3 PathwayYoshinori Kakutani, Atsushi Shioi, Tetsuo Shoji, et al.
Nutrients|December 28, 2021
Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis PatientsMasaaki Inaba, Katsuhito Mori, Yoshihiro Tsujimoto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 1, 2009
Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximabAkihiko Ban, Masaaki Inaba, Yutaka Furumitsu, et al.
Clinical Calcium|November 11, 2005
[Vascular calcification in advanced secondary hyperparathyroidism]Yasuo Imanishi, Takehisa Kawata, Keisuke Kobayashi, et al.
Life Sciences|June 28, 2005
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTHMisako Ueda, Masaaki Inaba, Senji Okuno, et al.
European Journal of Haematology|January 4, 2013
Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patientsShigeichi Shoji, Masaaki Inaba, Naohisa Tomosugi, et al.
Clinical Science (London, England : 1979)|February 6, 2004
Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesisReiko Okabe, Masaaki Inaba, Shinrei Sakai, et al.
Journal of Bone and Mineral Metabolism|March 5, 2004
Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinolineReiko Okabe, Masaaki Inaba, Kiyoshi Nakatsuka, et al.
Diabetes Research and Clinical Practice|June 27, 2017
Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?Masanori Abe, Takayuki Hamano, Junichi Hoshino, et al.
Pageof 43

Showing results (101-110 of 430) with videos related to

Sort By:
Pageof 43
Nephron|February 4, 2019
Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary HyperparathyroidismSenji Okuno, Masaaki Inaba, Eiji Ishimura, et al.
Journal of Cellular Biochemistry|March 5, 2015
Oncostatin M Promotes Osteoblastic Differentiation of Human Vascular Smooth Muscle Cells Through JAK3-STAT3 PathwayYoshinori Kakutani, Atsushi Shioi, Tetsuo Shoji, et al.
Nutrients|December 28, 2021
Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis PatientsMasaaki Inaba, Katsuhito Mori, Yoshihiro Tsujimoto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 1, 2009
Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximabAkihiko Ban, Masaaki Inaba, Yutaka Furumitsu, et al.
Clinical Calcium|November 11, 2005
[Vascular calcification in advanced secondary hyperparathyroidism]Yasuo Imanishi, Takehisa Kawata, Keisuke Kobayashi, et al.
Life Sciences|June 28, 2005
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTHMisako Ueda, Masaaki Inaba, Senji Okuno, et al.
European Journal of Haematology|January 4, 2013
Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patientsShigeichi Shoji, Masaaki Inaba, Naohisa Tomosugi, et al.
Clinical Science (London, England : 1979)|February 6, 2004
Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesisReiko Okabe, Masaaki Inaba, Shinrei Sakai, et al.
Journal of Bone and Mineral Metabolism|March 5, 2004
Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinolineReiko Okabe, Masaaki Inaba, Kiyoshi Nakatsuka, et al.
Diabetes Research and Clinical Practice|June 27, 2017
Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?Masanori Abe, Takayuki Hamano, Junichi Hoshino, et al.
Pageof 43